Generic Name and Formulations:
Clindamycin (as phosphate) 1%; foam; contains alcohol.
Indications for EVOCLIN:
Wash and dry skin. Apply once daily. Dispense an amount that will cover the affected area(s) into cap or other cool surface. Pick up a small amount of foam with fingertips and massage into affected area(s) until foam disappears.
History of regional enteritis, ulcerative or antibiotic-associated colitis (including pseudomembranous colitis).
Atopic patients. Discontinue if significant diarrhea, irritation, or dermatitis occurs. Avoid contact with eyes, mouth, lips, other mucous membranes or broken skin. Discontinue if no improvement after 6–8 weeks or if condition worsens. Product is flammable. Pregnancy (Cat.B). Nursing mothers: not recommended.
May potentiate neuromuscular blockers. Cross-resistance may occur with erythromycin. Prolonged and/or worsened severe colitis with antiperistaltic agents (eg, opiates, diphenoxylate with atropine).
Application site reactions (eg, burning, pruritus, dryness), headache, irritation, gram (–) folliculitis, abdominal pain, Gl disturbances; rare: diarrhea, pseudomembranous colitis.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|